VD's Model Portfolio & Discussion Thread Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (8729)	4/10/2001 1:06:33 PM
From: Arthur Radley	Read Replies (1) of 9719

Rick, As with you, the 500% factor of the growth of a tumor bothered me. Knowing that Dr. Tuszynski has a good reputation and MCP/Hahnemann University Hospital wasn't a new kid on the block, I decided to get a definitive answer to this "mystery" number. The following is the answer I got back from the company and it now makes sense...at least for the mouse model, as for human results I guess we will have to wait.. "The 560% reduction in growth means that tumors in control animals > receiving only saline grew 5.6 times larger than tumors in animals > receiving angiocidin treatment. Hope this answers your question. Thank > you for your interest in InKine.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next